Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 2
Submit an article Journal homepage
398
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of Treatments for Ocular Toxoplasmosis

Julio CasoyR&D Department, Inclinica, Wayne, Pennsylvania, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5328-8007
, MDORCID Icon,
Heloisa NascimentoDepartment of Ophthalmology and Visual Sciences of the Federal University of São Paulo, , São Paulo, Brazil;Instituto da Visão, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0003-0315-1317
, MD, PhDORCID Icon,
Luci Meire P. SilvaDepartment of Ophthalmology and Visual Sciences of the Federal University of São Paulo, , São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-9899-6461
, PhD, MBAORCID Icon,
Yuslay Fernández-ZamoraDepartment of Ophthalmology and Visual Sciences of the Federal University of São Paulo, , São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0003-3294-2871
, MDORCID Icon,
Cristina MuccioliDepartment of Ophthalmology and Visual Sciences of the Federal University of São Paulo, , São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-6870-6187
, MD, PhDORCID Icon,
João Rafael de Oliveira DiasDepartment of Ophthalmology and Visual Sciences of the Federal University of São Paulo, , São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-3641-3638
, MD, PhDORCID Icon,
Mário Junqueira NóbregaSadalla Amin Ghanem Eye Hospital, Joinville, Santa Catarina, Brazil;Ophthalmology Department , University of Joinville, Santa Catarina, BrazilORCID Iconhttps://orcid.org/0000-0001-6917-3856
, MD, PhDORCID Icon,
Heloísa Amaral Junqueira NóbregaOphthalmology Department of the Hans-Dieter Schmidt Hospital, , Joinville, Santa Catarina, BrazilORCID Iconhttps://orcid.org/0000-0002-7172-5047
, MDORCID Icon,
Jacqueline ZummoDepartment of Health Sciences, Nova Southeastern University, Fort Lauderdale, Florida, USAORCID Iconhttps://orcid.org/0000-0002-3439-5982
, PhD, MPH, MBAORCID Icon &
Rubens Belfort Jr.Department of Ophthalmology and Visual Sciences of the Federal University of São Paulo, , São Paulo, Brazil;Instituto da Visão, São Paulo, BrazilORCID Iconhttps://orcid.org/0000-0002-8422-3898
, MD, PhDORCID Icon show all
Pages 249-255 | Received 17 Aug 2018, Accepted 02 Jan 2019, Published online: 26 Feb 2019

References

  • Gonzalez Fernandez D, Nascimento H, Nascimento C, Muccioli C, Belfort R Jr. Uveitis in São Paulo, Brazil: 1053 new patients in 15 months. Ocul Immunol Inflamm. 2017;25(3):382–387. doi:10.3109/09273948.2015.1132741.
  • Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12(4):297–310. doi:10.1080/092739490500174.
  • Perkins ES, Schofield PB, Smith CH. Treatment of uveitis with pyrimethamine (daraprim). Br J Ophthalmol. 1956;40(10):577–586. doi:10.1136/bjo.40.10.577.
  • Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105(6):1032–1037. doi:10.1016/S0161-6420(98)96004-3.
  • Park YH, Nam HW. Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol. 2013;51(4):393–399. doi:10.3347/kjp.2013.51.4.393.
  • Commodaro AG, Belfort RN, Rizzo LV, et al. Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz. 2009;104(2):345–350.doi:10.1590/S0074-02762009000200030.
  • Rothova A, Buitenhuis HJ, Meenken C, et al. Therapy of ocular toxoplasmosis. Int Ophthalmol. 1989;13(6):415–419.doi:10.1007/BF02306491.
  • Soheilian M, Ramezani A, Azimzadeh A, et al. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118(1):134–141.doi:10.1016/j.ophtha.2010.04.020.
  • Novais EA, Commodaro AG, Santos F, et al. Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and blood. Br J Ophthalmol. 2014;98(7):937–940.doi:10.1136/bjophthalmol-2013-304184.
  • Lima GS, Saraiva PG, Saraiva FP. Current therapy of acquired ocular toxoplasmosis: a review. J Ocul Pharmacol Ther. 2015;31(9):511–517. doi:10.1089/jop.2015.0059.
  • Wakefield D, Cunningham ET Jr., Pavesio C, Garweg JG, Zierhut M. Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(1):2–9. doi:10.3109/09273948.2011.547157.
  • Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005;112(11):1876–1882.doi:10.1016/j.ophtha.2005.05.025.
  • Slatore CG, Tilles SA. Sulfonamide hypersensitivity. Immunol Allergy Clin North Am. 2004;24(3):477–490. vii. doi:10.1016/j.iac.2004.03.011.
  • Centers for Disease Control and Prevention. Parasites - Toxoplasmosis (Toxoplasma infection). Treatment. https://www.cdc.gov/parasites/toxoplasmosis/health_professionals/index.html. Published April 10, 2017. Accessed August 12, 2018.
  • Kim SJ, Scott IU, Brown GC, et al. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology. 2013;120(2):371–378.doi:10.1016/j.ophtha.2012.07.061.
  • Garweg JG, Stanford MR. Therapy for ocular toxoplasmosis: the future. Ocul Immunol Inflamm. 2013;21(4):300–305. doi:10.3109/09273948.2013.779724.
  • Silveira C, Belfort R Jr., Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41–46.doi:10.1016/S0002-9394(02)01527-1.
  • Silveira C, Muccioli C, Nussenblatt R, Belfort R Jr. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis: 10 years of follow-up. Ocul Immunol Inflamm. 2015;23(3):246–247. doi:10.3109/09273948.2014.964422.
  • Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31(4). doi:10.1128/CMR.00057-17.
  • Pradhan E, Bhandari S, Gilbert RE, Stanford M. Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Database Syst Rev. 2016;5:CD002218. doi:10.1002/14651858.CD002218.pub2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.